We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · January 08, 2021

Direct-Acting Antivirals in HIV/HCV–Coinfected Patients

Journal of Hepatology


Additional Info

Journal of Hepatology
Increased Mortality in HIV/HCV-Coinfected Compared to HCV-Monoinfected Patients in the DAA Era Due to Non-Liver-Related Death
J. Hepatol. 2021 Jan 01;74(1)37-47, M Chalouni, S Pol, P Sogni, H Fontaine, K Lacombe, J Marc-Lacombe, L Esterle, C Dorival, M Bourlière, F Bani-Sadr, V de Ledinghen, D Zucman, D Larrey, D Salmon, F Carrat, L Wittkop

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading